Co-founder Simon Elsässer interviewed by national TV

Epigenica’s CSO and co-founder Simon Elsässer was interviewed by Swedish TV4 to help viewers better understand click chemistry and the implications of this year’s winner of the Nobel Prize in Chemistry.

Published
Categorised as News

Epigenica participated at the Nordic Life Science Days 2022

Businessman using smartphone for select smiley face icon for client evaluation and customer satisfaction after use product and service concept.

Epigenica were happy to attend the Nordic Life Science Days 29-30th November. Thank you to all interesting people who met our representatives during the conference – both in one-on-one partnering meetings and during the networking events.

Published
Categorised as News

Epigenica joins KI Innovation’s DRIVE incubator

Epigenica is happy to have joined the DRIVE Business Incubator at Karolinska Institutet Innovation. DRIVE is a dedicated life science incubator program which supports successful commercial development of businesses.

Published
Categorised as News

Epigenica granted €150,000 from the ERC for a 2nd time

Epigenica has been awarded a Proof-of-Concept grant of €150,000 to begin commercialization of a new platform technology. The ERC PoC hmqPro will focus on developing novel highly-multiplexed, quantitative biomarker profiling.

Published
Categorised as News